Vaping cessation has emerged as a crucial focus for health organizations, particularly among young individuals who are increasingly drawn to nicotine products.A recent clinical trial conducted by Harvard-affiliated Mass General Brigham reveals that using varenicline, an FDA-approved smoking cessation pill, significantly enhances the likelihood of teens and young adults successfully quitting vaping.